Use of omalizumab and allergen-specific immunotherapy for the treatment of respiratory allergic diseases in children and adults
Allergen-specific immunotherapy is a method of treatment and prevention of respiratory allergic diseases. Carrying it out changes and improves the course of allergic diseases. One of the promising and new approaches is the combination of allergen-specific immunotherapy with one of the biological dru...
Saved in:
Main Authors: | A. S. Prilutskiy (Author), O. A. Prilutskaia (Author) |
---|---|
Format: | Book |
Published: |
Association of Paediatric Allergists and Immunologists of Russia (APAIR),
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
by: Andrzej Bozek, et al.
Published: (2022) -
The Effectiveness of Sublingual Allergen-Specific Immunotherapy in Children with Allergic Rhinitis
by: M.P. Prokhorova
Published: (2015) -
ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH POLLINOSIS
by: R. M. Torshkhoeva, et al.
Published: (2014) -
Allergen-Specific Immunotherapy in Children: Prospects of Prevention and Treatment
by: E. A. Vishnyova, et al.
Published: (2015) -
Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis
by: Wenlong Liu, et al.
Published: (2020)